CAPTRUST Financial Advisors’s Filana Therapeutics FLNA Stock Holding History

CAPTRUST Financial Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-891	Closed	-$25K	–	3675
2022 Q2	$25K	Buy	891 +14	+2%	+$354	﹤0.01%	3251
2022 Q1	$33K	Buy	877 +727	+485%	+$30.8K	﹤0.01%	3085
2021 Q4	$7K	Buy	150 +10	+7%	+$524	﹤0.01%	3923
2021 Q3	$9K	Hold	140	–	–	﹤0.01%	3684
2021 Q2	$12K	Buy	140 +136	+3,400%	+$7.29K	﹤0.01%	3453
2021 Q1	$0	Buy	+4	New	+$157	﹤0.01%	4456

Other funds holding FLNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CAPTRUST Financial Advisors's FLNA Position: Q3 2022 in Review

CAPTRUST Financial Advisors sold out of Filana Therapeutics (FLNA) in Q3 2022, closing a stake of 891 shares — an estimated $25K sold.

CAPTRUST Financial Advisors first reported a position in FLNA in Q1 2021 and held it in 6 quarters. The position peaked at $33K in Q1 2022. 175 funds tracked by Wall St. Rank hold FLNA as of Q3 2022.

CAPTRUST Financial Advisors reported no remaining Filana Therapeutics position as of Q3 2022 after selling out during the quarter.
CAPTRUST Financial Advisors sold 891 Filana Therapeutics shares in Q3 2022, an estimated $25K.
CAPTRUST Financial Advisors first reported a position in Filana Therapeutics in Q1 2021 and held it in 6 quarters.
CAPTRUST Financial Advisors's Filana Therapeutics position peaked at $33K in Q1 2022.
175 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2022, filed 16 Nov 2022.